Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Historical Holders from Q2 2018 to Q1 2025

Symbol: KZR on Nasdaq
Type / Class: Equity / COMMON-STOCK
Shares outstanding: 7,227,333
All holders as of 31 Mar 2025: Q1 2025
Total 13F shares, excl. options: 0
Holdings value: $0
Number of holders: 0
Number of sells: -1
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
Equal Talent Investments Ltd	8.66%	$487,037	616,502	Equal Talent Investments Limited	28 Feb 2025
Avidity Partners Management LP	6.9%	$397,054	502,600	Avidity Partners Management LP	31 Dec 2024
BML Investment Partners, L.P.	5.1%	$283,781	368,594	BML Investment Partners, L.P.	28 Feb 2025

Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q1	0	$0	-$2,838				0
2024 Q4	0	$0	-$28,947,595	$0	$0		0
2024 Q3	37,449,865	$28,947,595	+$900,937	$464	$10,670	$0.7732	54
2024 Q2	39,365,394	$23,615,883	-$3,995,490	$420	$1,920	$0.6	77
2024 Q1	44,720,608	$40,307,361	-$4,363,680	$541	$2,344	$0.9016	80
2023 Q4	49,383,993	$46,782,011	-$6,015,885	$758	$169,979	$0.9474	81
2023 Q3	55,483,503	$66,015,535	-$3,021,557	$683,705	$853,349	$1.19	81
2023 Q2	56,853,940	$139,289,225	-$10,696,353	$1,410,260	$1,761,550	$2.45	102
2023 Q1	60,086,283	$188,069,347	-$2,895,034	$1,771,893	$2,250,157	$3.13	135
2022 Q4	57,438,478	$404,373,495	-$10,789,742	$6,336	$1,292,544	$7.04	123
2022 Q3	57,567,548	$495,653,323	+$24,341,050	$192,000	$4,327,000	$8.61	131
2022 Q2	54,911,473	$454,020,310	+$61,154,299	$3,326,000	$27,920,000	$8.27	125
2022 Q1	44,191,085	$734,149,889	+$63,780,372	$2,481,000	$10,949,000	$16.62	121
2021 Q4	39,383,430	$658,088,801	+$203,357,999	$1,313,000	$4,455,000	$16.72	103
2021 Q3	28,072,081	$242,729,438	+$7,811,950		$980,000	$8.64	75
2021 Q2	27,643,703	$150,101,213	+$4,146,701	$0		$5.43	73
2021 Q1	26,470,809	$157,211,005	+$18,317,371	$71,000		$5.96	79
2020 Q4	23,537,490	$122,866,361	+$1,908,188	$69,000	$0	$5.22	75
2020 Q3	23,177,080	$112,175,583	-$609,875	$1,000	$49,000	$4.84	75
2020 Q2	23,193,481	$119,558,636	+$25,836,495	$270,000	$399,000	$5.18	82
2020 Q1	18,491,349	$80,617,885	+$40,696,616			$4.36	58
2019 Q4	9,173,287	$36,785,829	-$692,653			$4.01	54
2019 Q3	9,424,823	$30,911,164	-$5,442,310			$3.28	53
2019 Q2	10,011,636	$77,168,911	+$5,806,241			$7.71	53
2019 Q1	9,915,066	$175,891,040	+$12,160,103			$17.74	50
2018 Q4	9,337,563	$220,365,047	+$7,169,032			$23.6	40
2018 Q3	9,054,013	$193,850,000	+$20,016,802			$21.41	37
2018 Q2	8,162,306	$141,208,000	+$141,208,000			$17.3	27